Adrian R. Krainer

Director

Adrian R. Krainer (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Stoke Therapeutics, Inc. (STOK). The largest single filing was $1.3M of STOK (33,243 sh × $39.74, as filed), executed Mar 10.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$3.9M

shares × price, as filed

Last traded

Mar 10

Filed Mar 12

Median ADV $25.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $3.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

STOK

Stoke Therapeutics, Inc. STOK · 0 buys · 4 sells 4 filings

Recent filings

STOKSALE Stoke Therapeutics, Inc. View filing → $1.3M
33,243 sh × $39.74
Exec Mar 10
Filed Mar 12 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $287K
7,229 sh × $39.66
Exec Mar 2
Filed Mar 4 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $1.2M
40,472 sh × $29.72
Exec Nov 24 2025
Filed Nov 26 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $1.1M
40,472 sh across 2 lots
Exec Nov 14 2025
Filed Nov 18 2025 · 5:30 PM ET